XPANCEO has unveiled a trio of smart contact lens prototypes at MWC 2025 Technology showcased includes fully remote power transfer Other prototypes include a biosensing smart contact lesns, and a ...

A new kind of smart contact lens is poised to revolutionize how we monitor eye health. Designed to work even when the eyes are closed, this stretchable lens combines pressure and movement ...

XPANCEO secures $250M to accelerate development of AI-powered smart contact lenses for XR computing, bringing its valuation to $1.35B | XR News from Auganix.org ...

The pioneering deep tech company behind the world's first smart contact lenses raises $250 million at a $1.35 billion ...

Smart contact lenses may be the holy grail of wearables. I blame The Six Million Dollar Man, a 1970s-era TV show featuring a biomechanically-enhanced former astronaut who had, among other things ...

The company, which is developing “smart” contact lenses, is now valued at $1.35 billion following the closure of its series A funding round. The round was led by Opportunity Venture (Asia), a Hong ...

While the ability to reversibly change from clear to blue faded after 200 cycles, the researchers were targeting a disposable type of smart contact lens, so degradation of the display wasn’t ...

MWC 2025: Xpanceo wants to deliver AI features, supervision, and more from its smart contact lens. Amid the increased clamor for AR smart glasses and headsets over the last year, it’s become ...

“Our smart soft contact lenses retain the intrinsic lens features of lens power, biocompatibility, softness, transparency, wettability, oxygen transmissibility and overnight wearability. Having all ...

“The most common battery charging system for smart contact lenses requires metal electrodes in the lens, which are harmful if they are exposed to the naked human eye,” said Dr. Yun Jeonghun ...

The team’s results were published in Nature Communications in November. But notably, the smart contact lens seems yet to be tested on human eyes. POSTECH’s team did achieve success in vivo ...